Ipca Laboratories Ltd.

Financial

	Ipca Laboratories	Ajanta Pharma	Gland Pharma
Operational Metrics
Pharmaceutical Sector
Number of ANDA's Filed in USA	43.0 .	74.0 .	371.0 .
Number of ANDA's Approved By USFDA	21.0 .	54.0 .	318.0 .
Domestic Sales Growth - YoY	11.0 %	7.5 %	n/a
US DMF Filings	55.0 .	n/a	68.0 .
R&D as a % of Total Sales	2.64 %	5.0 %	4.9 %
Financials
5 yr Average ROE	14.77 %	21.63 %	14.74 %
5yr average Equity Multiplier	1.47	1.32	1.13
5yr Average Asset Turnover Ratio	0.79	0.84	0.53
5yr Avg Net Profit Margin	12.85 %	19.77 %	24.17 %
Price to Book	4.87	8.32	3.21
P/E	45.87	34.27	42.07
5yr Avg Cash Conversion Cycle	62.7 Days	-102.34 Days	72.51 Days
Inventory Days	101.09 Days	55.16 Days	117.52 Days
Days Receivable	63.37 Days	49.8 Days	78.29 Days
Days Payable	112.44 Days	195.69 Days	103.04 Days
5yr Average Interest Coverage Ratio	55.69	108.5	205.64
5yr Avg ROCE	18.16 %	27.48 %	19.61 %
5yr Avg Operating Profit Margin	19.9 %	27.65 %	32.0 %
5 yr average Debt to Equity	0.16	0.0	0.01
5yr CAGR Net Profit	-2.03 %	7.08 %	-0.01 %
5yr Average Return on Assets	10.46 %	16.51 %	13.18 %
Shareholdings
Promoter Holding	44.72 %	66.26 %	51.83 %
Share Pledged by Promoters	0.0	12.61 %	0.0
Change in Promoter Holding (3 Yrs)	-1.57 %	-4.22 %	-6.17 %
Change in Mutual Fund Holding (3 Yrs)	1.43 %	4.63 %	19.94 %

Business

	Ipca Laboratories	Ajanta Pharma	Gland Pharma
Product Wise Break-Up	Product Wise Break-Up Branded Generics 49.34 Formulations 31.07 Active Pharmaceutical Ingredient (API) 19.59 Pharmaceutical products 0 Injectables 0 Pharmaceuticals 0	Product Wise Break-Up Pharmaceutical 100.0 Pharmaceuticals 0 Injectables 0 Formulations 0 Branded Generics 0 Active Pharmaceutical Ingredient (API) 0	Product Wise Break-Up Pharmaceutical products 0 Pharmaceutical 100.0 Injectables 0 Formulations 0 Branded Generics 0 Active Pharmaceutical Ingredient (API) 0
Therapeutic Area Wise Break-Up - Domestic	Therapeutic Area Wise Break-Up - Domestic Pain 52.0 Cardiac Science 17.0 Dermatology 6.0 Anti-bacterial 6.0 Urology 4.0 Cough and colds 4.0 Central Nervous System (CNS) 3.0 Anti Malarials 3.0 Gastro Intestinal 2.0 Neutraceuticals 1.0 0 Others 2.0	Therapeutic Area Wise Break-Up - Domestic 0 Anti Malarials 0 Cough and colds 0 Neutraceuticals 0 Anti-bacterial 0 Gastro Intestinal 0 Dermatology 23.0 Pain 10.0 Urology 0 Cardiac Science 0 Central Nervous System (CNS) 0 Others 67.0	-
Location Wise Break-Up	Location Wise Break-Up India 46.34 USA 17.83 Europe 15.39 Africa 6.96 Asia Pacific 6.08 Australia 4.05 CIS 3.35 Asia 0 Canada, Australia & New Zealand 0 Canada 0	Location Wise Break-Up Europe 0 CIS 0 India 31.87 Canada, Australia & New Zealand 0 Asia Pacific 0 Canada 0 Australia 0 USA 28.07 Asia Pacific 26.17 Africa 13.9	Location Wise Break-Up Europe 19.66 CIS 0 India 3.68 Canada, Australia & New Zealand 4.22 Asia Pacific 0 Canada 0 Australia 0 USA 55.57 Asia 0 Africa 0 Others 16.87
Therapeutic Area Break-Up	Therapeutic Area Break-Up Cardiovascular & Anti Diabetics 25.0 Anti Malarials 24.0 NSAID 21.0 Neuro 7.0 GI 6.0 Cough 2.0 Nutraceuticals 0 Urology 0 Dermatology 0 Others 15.0	-	-

Ipca Laboratories Ltd.

SIGN UP FOR FREE